IQ4I Published a New Report on Vascular and Non-Vascular Stents Global Market

Stents are devices used in the body for treating weak or narrow blood vessels caused due to plaque formation. Stents helps in improvement of the blood flow and prevents the blood vessels from bursting. Increased preferences of minimally-invasive procedures, growing aging populations, increasing incidence of metabolic diseases, technological advancements in stent technologies such as bio-degradable polymer and polymer-free coated stents, bio-resorbable vascular scaffold (BVS) and improvement in healthcare infrastructure and services are driving the growth of the market. This report analyzes the stent market in terms of market revenue ($ million) for all segments. The global vascular and non-vascular market is valued at $8.3 billion in 2014.

Slashing prices of stents, less adoption and long-term efficacy of novel technologies, and side effects associated with stenting procedures such as allergic reactions, in-stent restenosis and stent thrombosis are hampering the market growth.

North America accounted for the largest share in 2014 due to the introduction of new technologies by leading players, growing awareness and increased prevalence of arterial diseases and Asia-pacific region is expected to grow at the highest CAGR during the forecast period due to government initiatives for modernization of healthcare infrastructure, and increasing focus of both international and domestic players on the stents market.